Shenzhen, China – MGI Tech Co., Ltd. (“MGI”), a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced that its latest mid-throughput sequencer DNBSEQ-T1+ (“T1+”) has received the CE mark under the EU certification framework. This certification paves the way for the T1+ to enter the EU market for both research and clinical applications, marking a significant […]

The new suite of products unlocks greater access to Hi-C metagenomic research, accelerating discovery from complex microbial communities in human and environmental research applications SEATTLE — Phase Genomics, Inc., a leader in genomic technology development, today announced the launch of its new ProxiMeta Starter and Elite Bundles, comprehensive product offerings that make genome- and mobilome-resolved metagenomics […]

Lausanne, Switzerland and Frederick, MD – Alithea Genomics, a pioneering biotech company based in Switzerland and the USA specializing in scalable RNA sequencing solutions, today announced the launch of MERCURIUS™ Total DRUG-seq, a new extraction-free, full-length transcriptome profiling library preparation kit designed to push the boundaries of high-throughput drug screens, toxicology screens and target validation […]

ANN ARBOR, Mich. and SAN DIEGO and KRAKÓW, Poland — Intelliseq, a leader in computational genomics and digital tools for clinical interpretation of genetic variation, today announced a strategic partnership with Genomenon, the company behind the industry-leading Cancer Knowledgebase (CKB). Through this collaboration, Intelliseq will incorporate Genomenon’s comprehensive somatic variant data into its flagship iFlow […]

Ann Arbor, MI, San Diego, CA & Kraków, Poland – Intelliseq, a leader in computational genomics and digital tools for clinical interpretation of genetic variation, today announced a strategic partnership with Genomenon, the company behind the industry-leading Cancer Knowledgebase (CKB). Through this collaboration, Intelliseq will incorporate Genomenon’s comprehensive somatic variant data into its flagship iFlow platform, further empowering laboratories, […]

Autoinjector Enables High-Throughput Genetic Manipulation Using Vision-Guided Precision Robotics MINNEAPOLIS–Objective Biotechnology, a pioneer in next-generation research tools, today announced the commercial launch of the Autoinjector, the first fully automated robotic system for microinjection in genetic research. Developed in collaboration with the University of Minnesota, the system was validated in a GENETICS study showing its speed, […]

A new open-access microbial phenotyping dataset will accelerate AI research and empower the global scientific community COVINA, Calif. – The Align Foundation, a nonprofit accelerating predictive biology through artificial intelligence (AI)-driven research infrastructure, today announced a collaboration with ATCC, the leading global nonprofit provider of microbial strains, cell lines, in vitro models, and standards, to […]

Aubagne, France Incoming Sartorius CEO Michael Grosse to become Chairman of the Board of Sartorius Stedim Biotech S.A. In its meeting, the Board of Directors of Sartorius Stedim Biotech S.A. (SSB) acknowledged the resignation of Dr. Joachim Kreuzburg as member of the Board as of June 30, 2025. As his replacement, the Board co-opted Dr. […]

USP employs mass photometry as key orthogonal method for empty/full characterization of AAV capsids Refeyn’s SamuxMP mass photometer for AAV analytics – used for characterizing the U.S. Pharmacopeia’s new adeno-associated virus (AAV) reference standards. For a high-resolution image, please contact omeea@alto-marketing.com Oxford, UK – Refeyn, the company behind pioneering mass photometry technology, announces that mass […]

Illumina Ventures leads round to accelerate Arima’s clinical expansion CARLSBAD, CA – Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced the appointment of Tom Willis, PhD, as chief executive officer and the close of a $22 million Series C financing led by Illumina […]